Skip to main content
. 2009 Oct;20(10):2171–2180. doi: 10.1681/ASN.2009030312

Figure 9.

Figure 9.

Effect of sSCF on E11.5 MMP9+/+ and MMP9−/− kidney apoptosis and ureteric bud branching. (A) Percentage of apoptotic cells in MMP9+/+ and MMP9−/− kidneys rescued (+SCF) or not with SCF. Microphotographs of ten different kidneys sampled from MMP9+/+ and MMP9−/− mice rescued or not with SCF were analyzed. (B) Concentration of active caspase-3 in MMP9+/+ and MMP9−/− kidneys rescued or not with SCF, n = 50. (C) Number of ureteric bud tips in MMP9+/+ and MMP9−/− kidneys rescued (+SCF) or not with SCF. Microphotographs of ten different kidneys sampled from MMP9+/+ and MMP9−/− mice rescued or not with SCF were analyzed. Note that the percentage of apoptosis, the concentration of active caspase-3 activity, and the number of ureteric bud tips are not statistically different in the MMP9+/+ kidney and in the MMP9−/− kidney supplemented with recombinant SCF. Values are mean ± SEM. ***P < 0.001 versus MMP9+/+-injected mice.